Tenofovir‐based rescue therapy in chronic hepatitis B patients with suboptimal responses to adefovir with prior lamivudine resistance

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-9071|87|9|1532-1538

ISSN： 0146-6615

Source： JOURNAL OF MEDICAL VIROLOGY, Vol.87, Iss.9, 2015-09, pp. : 1532-1538

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 6, 2015-06 ,pp. : 1013-1021

John Wiley & Sons Inc

Access to resources Recommend Favorite

Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 90, Iss. 3, 2018-03 ,pp. : 497-502

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of the efficacies of entecavir 0.5 and 1.0 mg combined with adefovir in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analogue treatments

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 6, 2015-06 ,pp. : 999-1007

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of Telbivudine and Entecavir Therapy on Nephritic Function and Drug Resistance in Patients with Hepatitis B Virus-Related Compensated Cirrhosis

By  

Cellular Physiology and Biochemistry, Vol. 40, Iss. 1-2, 2016-11 ,pp. : 370-378

Karger

Access to resources Recommend Favorite

Serum M2BPGi level is a novel predictive biomarker for the responses to pegylated interferon‐α treatment in HBeAg‐positive chronic hepatitis B patients

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 90, Iss. 4, 2018-04 ,pp. : 721-729

John Wiley & Sons Inc

Access to resources Recommend Favorite